Top gainers
US stocks that rose the most in the latest trading session.
Close on Nov 11, 2026
Top gainers, $300m+
100 stocks on Nov 11, 2026
| # | Company | Price | Change | Volume | Dollar volume | Market cap | YTD | 1Y |
|---|---|---|---|---|---|---|---|---|
| 1 | sfwlShengfeng Development | $5.00 | +43.88% | 185,862 | $929.31K | $412.49M | −64.91% | −66.33% |
| 2 | $1.82 | +30.94% | 30.64M | $55.76M | $449.97M | −9.00% | −12.92% | |
| 3 | $9.97 | +26.68% | 7.69M | $76.62M | $589.61M | +165.2% | +370.3% | |
| 4 | $11.22 | +26.49% | 10.07M | $112.99M | $652.32M | −61.12% | +80.97% | |
| 5 | $18.60 | +26.44% | 611,122 | $11.37M | $507.83M | +50.61% | +52.71% | |
| 6 | $60.77 | +24.71% | 165.13M | $10.04B | $33.52B | −15.14% | −31.25% | |
| 7 | $10.37 | +22.29% | 9.97M | $103.35M | $1.54B | +108.7% | +107.0% | |
| 8 | $5.19 | +21.26% | 17.02M | $88.33M | $1.44B | −60.80% | −59.77% | |
| 9 | $3.31 | +21.25% | 219,658 | $727.07K | $1.69B | −78.78% | −89.18% | |
| 10 | $48.90 | +20.80% | 2.49M | $121.69M | $2.14B | +47.02% | +59.49% | |
| 11 | $46.97 | +19.49% | 15.02M | $705.51M | $3.08B | +187.3% | +344.8% | |
| 12 | $8.51 | +18.85% | 1.84M | $15.65M | $456.39M | −53.14% | −45.10% | |
| 13 | $15.99 | +18.14% | 6.67M | $106.64M | $4.05B | – | – | |
| 14 | $1.81 | +17.53% | 29.76M | $53.87M | $1.16B | −77.38% | −91.74% | |
| 15 | $3.13 | +16.79% | 11.21M | $35.07M | $797.75M | +222.4% | +165.3% | |
| 16 | $5.96 | +16.63% | 9.58M | $57.11M | $2.96B | −5.70% | −2.93% | |
| 17 | zjylJin Medical International | $4.91 | +16.63% | 228,826 | $1.12M | $768.65M | +11.59% | −1.88% |
| 18 | $3.49 | +16.33% | 8.51M | $29.68M | $944.01M | −58.75% | −64.35% | |
| 19 | $6.62 | +16.14% | 80,770 | $534.70K | $727.35M | +3293% | +3419% | |
| 20 | hlpHongli | $4.37 | +15.92% | 815,371 | $3.56M | $320.93M | +320.2% | +158.5% |
| 21 | $37.09 | +15.73% | 3.07M | $113.88M | $4.01B | −13.82% | +2.35% | |
| 22 | $55.86 | +15.60% | 15.91M | $888.55M | $4.72B | +60.24% | +135.2% | |
| 23 | $7.38 | +15.49% | 3.53M | $26.07M | $586.62M | −41.61% | −41.38% | |
| 24 | $6.28 | +15.34% | 1.57M | $9.88M | $510.51M | −62.15% | −56.27% | |
| 25 | $58.63 | +15.21% | 4.46M | $261.52M | $3.50B | +79.13% | +139.7% | |
| 26 | $4.30 | +14.97% | 5.61M | $24.12M | $803.05M | −7.92% | −22.10% | |
| 27 | $15.95 | +14.58% | 907,881 | $14.48M | $1.53B | −13.78% | – | |
| 28 | $11.80 | +14.56% | 3.14M | $37.07M | $1.18B | +47.32% | +80.70% | |
| 29 | $24.57 | +14.39% | 12.11M | $297.45M | $7.48B | – | – | |
| 30 | $1.99 | +14.37% | 25.93M | $51.61M | $724.69M | −82.64% | −89.25% | |
| 31 | $5.26 | +14.10% | 16.01M | $84.22M | $364.30M | −19.20% | +13.12% | |
| 32 | $4.38 | +14.06% | 1.85M | $8.09M | $517.64M | −4.99% | −11.16% | |
| 33 | $12.94 | +13.71% | 13.11M | $169.68M | $3.81B | – | – | |
| 34 | $977.69 | +13.69% | 16.40M | $16.04B | $139.11B | +311.9% | +260.0% | |
| 35 | $26.42 | +13.29% | 3.46M | $91.29M | $945.93M | +1291% | −80.43% | |
| 36 | $10.43 | +13.25% | 2.21M | $23.00M | $405.19M | −33.99% | −59.59% | |
| 37 | $15.97 | +13.18% | 10.64M | $169.94M | $6.24B | −28.58% | −48.05% | |
| 38 | $209.47 | +12.97% | 18.77M | $3.93B | $61.93B | +141.1% | +64.85% | |
| 39 | $19.06 | +12.85% | 6.11M | $116.37M | $2.25B | +8.54% | +12.85% | |
| 40 | $26.61 | +12.28% | 7.08M | $188.29M | $4.45B | +18.95% | +39.10% | |
| 41 | $8.83 | +12.20% | 3.62M | $31.94M | $1.94B | +407.5% | +407.5% | |
| 42 | $6.41 | +12.06% | 2.00M | $12.81M | $531.96M | +126.5% | +77.07% | |
| 43 | $203.36 | +12.05% | 6.80M | $1.38B | $216.39B | +86.04% | +35.81% | |
| 44 | $3.72 | +12.05% | 4.41M | $16.41M | $691.45M | +58.97% | +32.86% | |
| 45 | $811.30 | +11.89% | 36.71M | $29.78B | $917.92B | +184.3% | +236.5% | |
| 46 | $95.78 | +11.85% | 1.72M | $164.53M | $7.48B | +71.71% | +84.51% | |
| 47 | $26.69 | +11.81% | 939,991 | $25.09M | $1.34B | +15.59% | −2.59% | |
| 48 | $373.68 | +11.75% | 9.31M | $3.48B | $237.59B | +196.9% | +169.3% | |
| 49 | $9.59 | +11.38% | 944,295 | $9.06M | $395.59M | +0.74% | +22.95% | |
| 50 | $59.95 | +11.37% | 3.17M | $189.97M | $5.46B | +243.9% | +305.1% | |
| 51 | $154.22 | +11.29% | 3.31M | $510.38M | $23.56B | +83.05% | +84.30% | |
| 52 | $50.33 | +11.25% | 753,210 | $37.91M | $1.22B | +76.60% | +75.30% | |
| 53 | $10.40 | +11.11% | 290,662 | $3.02M | $856.72M | – | – | |
| 54 | $14.57 | +10.97% | 29.29M | $426.70M | $4.68B | +0.07% | −15.88% | |
| 55 | $11.72 | +10.88% | 406,076 | $4.76M | $514.91M | +94.04% | +94.04% | |
| 56 | indpIndaptus Therapeutics | $3.21 | +10.69% | 264,984 | $850.60K | $427.71M | +10.31% | +18.01% |
| 57 | $648.06 | +10.67% | 6.46M | $4.18B | $58.13B | +75.82% | +156.7% | |
| 58 | $3.95 | +10.64% | 3.85M | $15.19M | $392.82M | −66.09% | −54.96% | |
| 59 | $8.04 | +10.59% | 1.82M | $14.63M | $703.48M | −67.84% | −1.83% | |
| 60 | $38.10 | +10.53% | 6.17M | $235.12M | $9.44B | −3.50% | +11.21% | |
| 61 | $8.83 | +10.51% | 2.26M | $19.97M | $546.58M | +89.48% | +56.84% | |
| 62 | $65.78 | +10.42% | 2.93M | $192.92M | $2.15B | +225.8% | +184.0% | |
| 63 | $13.47 | +10.41% | 274,671 | $3.70M | $448.43M | +529.4% | +529.4% | |
| 64 | $6.79 | +10.41% | 710,096 | $4.82M | $438.11M | +13.17% | +20.82% | |
| 65 | $7.24 | +10.37% | 2.68M | $19.40M | $458.93M | −59.78% | −69.73% | |
| 66 | $122.77 | +10.36% | 3.43M | $420.68M | $17.44B | +66.85% | +85.85% | |
| 67 | $125.22 | +10.34% | 3.07M | $383.95M | $11.69B | +69.93% | +73.92% | |
| 68 | $48.07 | +10.33% | 865,441 | $41.60M | $1.56B | +211.1% | +227.9% | |
| 69 | $49.25 | +10.33% | 2.79M | $137.60M | $2.97B | +151.8% | +136.0% | |
| 70 | $249.86 | +10.32% | 1.70M | $425.66M | $19.08B | +45.88% | +46.99% | |
| 71 | $4.30 | +10.26% | 12.85M | $55.24M | $779.92M | +23.92% | +9.69% | |
| 72 | $5.59 | +10.26% | 10.62M | $59.38M | $739.51M | −11.69% | +5.67% | |
| 73 | $26.94 | +10.18% | 543,545 | $14.64M | $758.47M | +25.19% | +3.30% | |
| 74 | $8.47 | +10.14% | 1.85M | $15.63M | $559.13M | −41.18% | −26.67% | |
| 75 | $72.90 | +10.05% | 657,258 | $47.91M | $5.62B | +48.81% | −14.79% | |
| 76 | $551.72 | +9.99% | 7.64M | $4.21B | $126.65B | +100.3% | +91.57% | |
| 77 | $8.62 | +9.95% | 1.43M | $12.35M | $312.84M | −49.65% | −55.73% | |
| 78 | $5.20 | +9.94% | 11.37M | $59.12M | $800.84M | −43.60% | −43.54% | |
| 79 | $7.14 | +9.68% | 6.48M | $46.28M | $1.91B | +87.89% | +190.2% | |
| 80 | $7.03 | +9.67% | 10.80M | $75.89M | $1.66B | −37.29% | −53.20% | |
| 81 | $15.10 | +9.66% | 4.69M | $70.82M | $11.33B | – | – | |
| 82 | $3.87 | +9.63% | 13.47M | $52.13M | $703.72M | −16.05% | −9.79% | |
| 83 | $87.15 | +9.60% | 4.26M | $370.84M | $10.25B | +81.11% | +74.30% | |
| 84 | $30.43 | +9.50% | 42.85M | $1.30B | $19.99B | +3.96% | −21.61% | |
| 85 | $9.97 | +9.44% | 1.37M | $13.68M | $920.11M | +240.3% | +231.2% | |
| 86 | $52.79 | +9.41% | 133,759 | $7.06M | $1.85B | +78.16% | +138.9% | |
| 87 | $3.16 | +9.34% | 3.98M | $12.57M | $489.47M | +93.87% | +58.79% | |
| 88 | $168.80 | +9.33% | 33.94M | $5.73B | $148.02B | +98.63% | +88.96% | |
| 89 | $1.64 | +9.33% | 28.60M | $46.91M | $584.58M | −68.09% | −74.29% | |
| 90 | $11.25 | +9.33% | 247,325 | $2.78M | $302.60M | −27.47% | −15.98% | |
| 91 | $0.9645 | +9.33% | 5.60M | $5.40M | $930.66M | −49.77% | −56.55% | |
| 92 | $11.10 | +9.25% | 5.21M | $57.78M | $1.14B | −27.64% | −28.11% | |
| 93 | $234.51 | +9.25% | 11.47M | $2.69B | $45.92B | +27.06% | +48.41% | |
| 94 | $53.82 | +9.19% | 272,342 | $14.66M | $716.90M | +39.79% | +60.13% | |
| 95 | $30.86 | +9.12% | 844,341 | $26.06M | $933.80M | +55.78% | +63.02% | |
| 96 | tronTron | $1.58 | +8.97% | 546,296 | $863.15K | $749.52M | +27.42% | −31.00% |
| 97 | $78.70 | +8.96% | 3.08M | $242.21M | $8.29B | +14.06% | +15.96% | |
| 98 | $7.42 | +8.96% | 1.29M | $9.55M | $490.09M | +11.58% | +6.15% | |
| 99 | $141.41 | +8.94% | 8.40M | $1.19B | $26.58B | −1.72% | −10.78% | |
| 100 | $10.85 | +8.94% | 195,931 | $2.13M | $434.00M | +664.1% | +569.8% |
End-of-day prices, adjusted for splits. Only common stocks with a price from the latest session are ranked. See the market heatmap or all US stocks.